Terms: = Ovarian cancer AND MAPK1, MAPK2, 5594, ENSG00000100030, P28482, ERK2, p40, PRKM1, p38, p41, ERT1, p41mapk, PRKM2, P42MAPK, ERK AND Staging
5 results:
1. Primary squamous cell carcinoma of the ovary accompanied by transition of a mucinous borderline ovarian tumor.
Bak S; Hong JY; Lee JW; Im S; Park DC
J Int Med Res; 2023 Feb; 51(2):3000605221098177. PubMed ID: 36734245
[TBL] [Abstract] [Full Text] [Related]
2. Low Expression of Rasal2 Promotes Non-small Cell Lung cancer Metastasis through Ras/erk Pathway.
Fan D; Yu S; Yang Y; Qu S
Biol Pharm Bull; 2021; 44(7):992-998. PubMed ID: 34193694
[TBL] [Abstract] [Full Text] [Related]
3. Determination of Potential Therapeutic Targets and Prognostic Markers of ovarian cancer by Bioinformatics Analysis.
Zhang J; Huang S; Quan L; Meng Q; Wang H; Wang J; Chen J
Biomed Res Int; 2021; 2021():8883800. PubMed ID: 33829065
[TBL] [Abstract] [Full Text] [Related]
4. ovarian teratoma in children: a plea for collaborative clinical study.
Łuczak J; Bagłaj M
J Ovarian Res; 2018 Aug; 11(1):75. PubMed ID: 30165903
[TBL] [Abstract] [Full Text] [Related]
5. Lewis Y regulates signaling molecules of the transforming growth factor β pathway in ovarian carcinoma-derived RMG-I cells.
Li FF; Liu JJ; Liu DW; Lin B; Hao YY; Cong JP; Zhu LC; Gao S; Zhang SL; Iwamori M
Int J Oncol; 2012 Apr; 40(4):1196-202. PubMed ID: 22179544
[TBL] [Abstract] [Full Text] [Related]
